O7.2Phase 1 first-in-human study of the enhancer of zeste-homolog 2 (EZH2) histone methyl transferase inhibitor E7438.

 

Annals of Oncology

Mars 2015
O7.2Phase 1 first-in-human study of the enhancer of zeste-homolog 2 (EZH2) histone methyl transferase inhibitor E7438.

Ribrag V, Soria JC, Reyderman L, Chen R, Salazar P, Kumar N, Kuznetsov G, Keilhack H, Ottesen LH, Italiano A.